Ramphul Kamleshun, Mejias Stephanie Gonzalez
Department of Pediatrics, Shanghai Xin Hua Hospital affiliated to the Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Department of Pediatrics, Robert Reid Cabral Children's Hospital affiliated to the University Iberoamericana UNIBE, School of Medicine, Santo Domingo, Dominican Republic.
Arch Med Sci Atheroscler Dis. 2018 Mar 21;3:e41-e45. doi: 10.5114/amsad.2018.74522. eCollection 2018.
Kawasaki disease is an acute systemic vasculitis that was first reported in 1961. Over the last 5 decades multiple papers have been published to further understand this disease. The diagnosis of Kawasaki disease is made based on the clinical findings. Atypical Kawasaki disease includes patients who do not meet all the criteria for diagnosis. The main complication of Kawasaki disease is coronary aneurysm, and the treatment is intravenous immunoglobulin and aspirin. A second dose of immunoglobulin is given if the patient does not improve, and several other treatment options have been proposed over the last few years as second and third line options.
川崎病是一种急性全身性血管炎,于1961年首次报道。在过去的50年里,发表了多篇论文以进一步了解这种疾病。川崎病的诊断基于临床发现。非典型川崎病包括不符合所有诊断标准的患者。川崎病的主要并发症是冠状动脉瘤,治疗方法是静脉注射免疫球蛋白和阿司匹林。如果患者没有改善,则给予第二剂免疫球蛋白,并且在过去几年中已经提出了几种其他治疗方案作为二线和三线选择。